Financials • Specialty Insurers
$67.84 ▲ +1.96
(+2.98%)
MKT CAP: $22.50B • VOL: 2.85M
52W L $54 52W H $83
BRO // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.90B | $4.80B | $4.26B |
| YoY Revenue Growth % | +22.8% | +12.9% | — |
| Gross Profit | $2.60B | $2.11B | $1.87B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.24B | $1.17B | $1.03B |
| Operating Margin % | 21.1% | 24.4% | 24.1% |
| Net Income (GAAP) | $1.05B | $993.0M | $871.0M |
| EBITDA (Normalized) | $1.30B | $1.24B | $1.18B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.45B | $1.17B | $1.01B |
| Capital Expenditures (CapEx) | $68.0M | $82.0M | $191.6M |
| Free Cash Flow (FCF) | $1.38B | $1.09B | $818.4M |
| FCF Margin % | 23.4% | 22.7% | 19.2% |
| Return on Invested Capital (ROIC %) | 4.9% | 8.1% | 10.9% |
| Cash & Short-Term Equivalents | $1.08B | $675.0M | $1.36B |
| Total Debt (Short + Long Term) | $6.89B | $3.60B | $2.90B |
| Total Stockholders' Equity | $14.40B | $8.45B | $5.94B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR BRO.